Detalles de la búsqueda
1.
Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval.
Ann Hematol
; 101(1): 131-137, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625831
2.
Real-world treatment patterns of metastatic non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors.
Cancer Med
; 12(1): 159-169, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35702932
3.
Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs.
J Comp Eff Res
; 12(11): e230107, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37655686
4.
Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs.
J Med Econ
; 26(1): 843-849, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294103
5.
Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational study.
Cancer Treat Res Commun
; 36: 100742, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478531
6.
Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs.
Rheumatol Ther
; 9(4): 1091-1107, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35604547
7.
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia.
Leuk Res
; 115: 106809, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220060
8.
Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugs.
J Med Econ
; 24(1): 299-307, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502940
9.
Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting.
Curr Med Res Opin
; 37(7): 1189-1197, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944646
10.
Burden of illness among Medicare and non-Medicare US populations with acquired thrombotic thrombocytopenic purpura.
J Med Econ
; 24(1): 706-716, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33904347
11.
Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis.
Clin Lymphoma Myeloma Leuk
; 21(1): e1-e9, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33184000
12.
Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis.
Urol Oncol
; 39(10): 733.e1-733.e10, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34238657
Resultados
1 -
12
de 12
1
Próxima >
>>